Meridia
- Click here to request
information on how your firm can be listed here.
Meridia (sibutramine hydrochloride monohydrate) is a perscription medication
for the treatment of obesity. It has been used by more than 8.5 million people
in 70 countries since 1997.
On March 19, 2002, the group Public Citizen submitted a petition to the US
Food and Drug Administration (FDA), asking that Meridia be removed from the
market due to concerns over its safety and effectiveness. Abbott Laboratories,
the manufactuter of Meridia, has disputed the claims in the petition and has
reaffirmed the safety and effectiveness of Meridia. Public Citizen's petition
is currently under review by the FDA.
At least one class action has been filed in connection with Meridia.
- Meridia® Product Information
Abbott Laboratories
- Abbott
Outlook Cut on Plant Woes, Meridia FindLaw Legal News, June 11, 2002
- Abbott Laboratories
Reaffirms Safety, Effectiveness of Meridia® (Sibutramine HCl Monohydrate CIV
Capsules) (PDF) Abbott Laboratories, May 21, 2002
- Letter
to HHS Urging That Criminal Charges Be Brought Against Abbott Laboratories
for Illegally Withholding Information Concerning Eight Deaths and Other Adverse
Effects of the Drug Sibutramine Public Citizen, May 21, 2002
- Health
Canada Investigates Safety of Meridia® (Sibutramine) Health Canada, March
27, 2002
- Abbott
Laboratories Reassures Patients of the Efficacy and Safety of Meridia® (Sibutramine)
and Denounces Public Citizen's Petition to the U.S. Food and Drug Administration
As Incorrect and Misleading Abbott Laboratories, March 20, 2002
- Consumer
Group Seeks Meridia Ban USAToday.com, March 19, 2002
- FDA
Should Immediately Ban Dangerous Diet Drug Meridia Public Citizen, March
19, 2002
- The petition referenced in this press release can be viewed here,
and a response to the petition (from Abbott Laboratories) can be viewed
here.
|
